The Effect of Nutrient Sequencing in Healthy Adults

ClinicalTrials.gov ID: NCT07873437

Public ClinicalTrials.gov record NCT07873437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 16, 2026, 4:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

There is emerging evidence that the order in which food is consumed in a meal, known as the "nutrient sequence", can have protective health effects against obesity and metabolic disease. These studies show that consuming food sources rich in protein before consuming carbohydrates will significantly lower blood glucose levels equivalent to many glucose-lowering medications. This nutrition intervention can have tremendous therapeutic potential in individuals who are pre-diabetic and prevent the onset of obesity. Surprisingly, however, there are no studies to date that have comprehensively tested this efficacy in young health adults. This research proposal will define the response of nutrient sequencing in young healthy individuals to determine if this intervention can improve metabolic profiles such as normalizing blood glucose levels to healthy parameters in order to prevent obesity and type 2 diabetes. We will 1) test if the metabolic benefits of Nutrient Sequencing can extend across different populations in NY state, and 2) define the mechanism of the metabolic response to nutrient sequencing interventions by capturing participant circulating blood proteome and metabolome.

Study identification

NCT ID: NCT07873437
Recruitment status: Active, not recruiting
Study type: Interventional
Phase: Not applicable
Lead sponsor: Cornell University; Other
Enrollment: 40 participants

Conditions and interventions

Conditions

Pre Diabetes

Interventions

Procedure · Behavioral

Eligibility (public fields only)

Age range: 18 Years to 35 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 1, 2026 (Actual)
Primary completion: Oct 1, 2028 (Estimated)
Completion: Oct 1, 2028 (Estimated)
Last update posted: Oct 14, 2026

2026 – 2028

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Cornell University	Ithaca	New York	14850	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07873437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 14, 2026 · Synced Oct 16, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07873437 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →